-
Vanderbilt-Discovered Compound Advances to Phase 1 Clinical Trial as a Promising New Treatment for Schizophrenia
Neumora Therapeutics, Inc. has announced the launch of a Phase 1 clinical study evaluating NMRA-861 in healthy adult participants and adults with stable schizophrenia. -
Vanderbilt announces Innovation Catalyst Fund awardees for February 2025 cycle
Vanderbilt has announced eleven awardees in the latest round of its Innovation Catalyst Fund, an initiative that supports translational research that has promising commercial potential -
Vanderbilt Collaborates with a Global Transportation Company to Advance Mobility Solutions on I-24 Motion
Together, Vanderbilt and Cintra are turning research into innovation—using insights from I-24 MOTION to directly influence Cintra’s product development, business operations, and R&D strategy. -
Seven Vanderbilt Faculty Research Projects Get Innovation Catalyst Funding
Vanderbilt has announced seven awardees in the latest round of its Innovation Catalyst Fund, an initiative that supports translational research that has promising commercial potential.